Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

BETEFLAM

CIPHER PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is BETEFLAM discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that BETEFLAM 0.1% has been permanently discontinued (last updated August 8, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength0.1%
Last updated2020-08-08

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

VALISONE

BAUSCH HEALTH, CANADA INC.

0.1% · DIN 00027944

Same strengthDifferent dosage formSame routeNo current shortage

CELESTODERM V CRM 0.1%

SCHERING-PLOUGH CANADA INC

0.1% · DIN 00027901

Same strengthDifferent dosage formSame routeNo current shortage

BETADERM CRM 0.1%

TARO PHARMACEUTICALS INC

0.1% · DIN 00716626

Same strengthDifferent dosage formSame routeNo current shortage

BETADERM LOTION 0.1%

TARO PHARMACEUTICALS INC

0.1% · DIN 00716634

Same strengthDifferent dosage formSame routeNo current shortage

CELESTODERM V ONT 0.1%

SCHERING-PLOUGH CANADA INC

0.1% · DIN 00028363

Same strengthDifferent dosage formSame routeNo current shortage

BETNOVATE LOT 0.1%

GLAXO CANADA INC

.1% · DIN 00011940

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02449773

Strength

0.1%

Dosage Form

PATCH

Route

TOPICAL

Active Ingredient

BETAMETHASONE VALERATE

See all BETAMETHASONE VALERATE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

Other Products from CIPHER PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.